Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

This study has been completed.
Sponsor:
Information provided by:
PETHEMA Foundation
ClinicalTrials.gov Identifier:
NCT00388531
First received: October 16, 2006
Last updated: September 16, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)